The drugmaker will cap the monthly cost of the medication at $35 per month for those policyholders. Pharmaceutical company Eli Lilly & Co. has announced that it will reduce the price tag on its most commonly prescribed insulin products for private health insurance customers. This discount is by 70 percent, with a cap at $35 per month at certain retail pharmacies. The price of the Lispro injection will be discounted to $25 per vial, starting on May 1, 2023. Lilly also announced that it would be reducing the price of…
Read MorePrivate health insurance customers get 70% Eli Lilly insulin drug discount
